The Genetics and Epigenetics of Fatigue

PM and R

Volumn 2, Issue 5, 2010, Pages 456-465

  Landmark Høyvik, Hege ^a   Reinertsen, Kristin V ^b   Loge, Jon H ^b   Kristensen, Vessela N ^a   Dumeaux, Vanessa ^c   Fosså, Sophie D ^b   Børresen Dale, Anne Lise ^a   Edvardsen, Hege ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; BIOINFORMATICS; DEACETYLATION; DISEASE SEVERITY; EPIGENETICS; FATIGUE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INNATE IMMUNITY; MINING; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID FUNCTION;

COMPUTATIONAL BIOLOGY; EPIGENESIS, GENETIC; FATIGUE; FATIGUE SYNDROME, CHRONIC; HUMANS; IMMUNE SYSTEM; MENTAL FATIGUE; POLYMORPHISM, SINGLE NUCLEOTIDE; RESEARCH DESIGN; THYROID GLAND;

EID: 77952833295     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.04.003     Document Type: Article

References (50)

1. Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med 134 (2001) 838-843
2. Wessely S., Hotopf M., and Sharpe M. Chronic Fatigue and its Syndromes (1998), Oxford University Press, Oxford, UK
3. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121 (1994) 953-959
4. Loge J.H., Ekeberg O., and Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45 (1998) 53-65
5. Prins J.B., van der Meer J.W., and Bleijenberg G. Chronic fatigue syndrome. Lancet 367 (2006) 346-355
6. Wessely S. Chronic fatigue syndrome: A 20th century illness?. Scand J Work Environ Health 23 Suppl 3 (1997) 17-34
7. Ryan J.L., Carroll J.K., Ryan E.P., Mustian K.M., Fiscella K., and Morrow G.R. Mechanisms of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 22-34
8. Cook Jr. E.H., and Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 455 (2008) 919-923
9. Vernon S.D., Whistler T., Aslakson E., Rajeevan M., and Reeves W.C. Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics 7 (2006) 211-218
10. Aspler A.L., Bolshin C., Vernon S.D., and Broderick G. Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct 4 (2008) 44
11. Fang H., Xie Q., Boneva R., Fostel J., Perkins R., and Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 7 (2006) 429-440
12. Whistler T., Taylor R., Craddock R.C., Broderick G., Klimas N., and Unger E.R. Gene expression correlates of unexplained fatigue. Pharmacogenomics 7 (2006) 395-405
13. Presson A.P., Sobel E.M., Papp J.C., et al. Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol 2 (2008) 95
14. Fuite J., Vernon S.D., and Broderick G. Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: An exploratory analysis. Genomics 92 (2008) 393-399
15. Bhattacharjee M., Botting C.H., and Sillanpaa M.J. Bayesian biomarker identification based on marker-expression proteomics data. Genomics 92 (2008) 384-392
16. Emmert-Streib F. The chronic fatigue syndrome: A comparative pathway analysis. J Comput Biol 14 (2007) 961-972
17. Fostel J., Boneva R., and Lloyd A. Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis. Pharmacogenomics 7 (2006) 441-454
18. Broderick G., Craddock R.C., Whistler T., Taylor R., Klimas N., and Unger E.R. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 7 (2006) 407-419
19. Carmel L., Efroni S., White P.D., Aslakson E., Vollmer-Conna U., and Rajeevan M.S. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 7 (2006) 375-386
20. Whistler T., Unger E.R., Nisenbaum R., and Vernon S.D. Integration of gene expression, clinical, and epidemiologic data to characterize chronic fatigue syndrome. J Transl Med 1 (2003) 10
21. Lee E., Cho S., Kim K., and Park T. An integrated approach to infer causal associations among gene expression, genotype variation, and disease. Genomics 94 (2009) 269-277
22. Hampton T. Researchers find genetic clues to chronic fatigue syndrome. JAMA 295 (2006) 2466-2467
23. Gow J.W., Hagan S., Herzyk P., Cannon C., Behan P.O., and Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genom 2 (2009) 38
24. Cameron B., Galbraith S., Zhang Y., et al. Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J Infect Dis 196 (2007) 56-66
25. Bull S.J., Huezo-Diaz P., Binder E.B., et al. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 14 (2009) 1145
26. Flachenecker P., Bihler I., Weber F., Gottschalk M., Toyka K.V., and Rieckmann P. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 10 (2004) 165-169
27. van der Deure W.M., Appelhof B.C., Peeters R.P., et al. Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clin Endocrinol (Oxf) 69 (2008) 804-811
28. Aouizerat B.E., Dodd M., Lee K., et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 11 (2009) 27-41
29. Collado-Hidalgo A., Bower J.E., Ganz P.A., Irwin M.R., and Cole S.W. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav Immun 22 (2008) 1197-1200
30. Landmark-Hoyvik H., Reinertsen K.V., Loge J.H., Fossa S.D., Borresen-Dale A.L., and Dumeaux V. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenom J 9 (2009) 333-340
31. Vernon S.D., and Reeves W.C. The challenge of integrating disparate high-content data: Epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics 7 (2006) 345-354
32. Steinau M., Unger E.R., Vernon S.D., Jones J.F., and Rajeevan M.S. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med 82 (2004) 750-755
33. Torpy D.J., Bachmann A.W., Gartside M., et al. Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism. Endocr Res 30 (2004) 417-429
34. Smith A.K., Dimulescu I., Falkenberg V.R., et al. Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology 33 (2008) 188-197
35. Ortega-Hernandez O.D., Cuccia M., Bozzini S., et al. Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: Are they associated with age at onset and specific symptoms?. Ann N Y Acad Sci 1173 (2009) 589-599
36. Sorensen B., Jones J.F., Vernon S.D., and Rajeevan M.S. Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med 15 (2009) 34-42
37. Carlo-Stella N., Badulli C., Silvestri De, et al. A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 24 (2006) 179-182
38. Smith J., Fritz E.L., Kerr J.R., Cleare A.J., Wessely S., and Mattey D.L. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol 58 (2005) 860-863
39. Metzger K., Fremont M., Roelant C., and De M.K. Lower frequency of IL-17F sequence variant (His161Arg) in chronic fatigue syndrome patients. Biochem Biophys Res Commun 376 (2008) 231-233
40. Saiki T., Kawai T., Morita K., et al. Identification of marker genes for differential diagnosis of chronic fatigue syndrome. Mol Med 14 (2008) 599-607
41. Kerr J.R., Petty R., Burke B., et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis 197 (2008) 1171-1184
42. Whistler T., Jones J.F., Unger E.R., and Vernon S.D. Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol 5 (2005) 5
43. Vernon S.D., Unger E.R., Dimulescu I.M., Rajeevan M., and Reeves W.C. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 18 (2002) 193-199
44. Rajeevan M.S., Smith A.K., Dimulescu I., et al. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav 6 (2007) 167-176
45. Smith A.K., White P.D., Aslakson E., Vollmer-Conna U., and Rajeevan M.S. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 7 (2006) 387-394
46. Narita M., Nishigami N., Narita N., et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 311 (2003) 264-266
47. Kaushik N., Fear D., Richards S.C., et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 58 (2005) 826-832
48. Kerr J.R., Burke B., Petty R., et al. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: A detailed analysis of gene networks and clinical phenotypes. J Clin Pathol 61 (2008) 730-739
49. Golumbek P.T., Keeling R.M., and Connolly A.M. RAG2 gene knockout in mice causes fatigue. Muscle Nerve 36 (2007) 471-476
50. Krzyszton C.P., Sparkman N.L., Grant R.W., et al. Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. Am J Physiol Regul Integr Comp Physiol 295 (2008) R1109-R1114